SCR-LIP-000461 · Claim · machine-readable JSON →

This hypothesis paper on a mast cell/type-2 immune endotype of lipedema lists ADHD-related concepts only within a dedicated exploratory section as a secondary, untested hypothesis not required for its central mast cell-histamine-pain framework.

Retired in the claim consolidation (R-CLM-19): its source was judged not to be a finding on any question (e.g. a protocol, a truncated abstract or an off-topic paper). Kept for the record; see the change log below.

Claim at a glance
Type
clinical association
Knowledge state
Emerging
Evidence certainty
very low (GRADE)
Evidence
1 source(s)
Dates
2026-11-17 → 2026-11-17

Structured evidence, machine-compiled — not a verdict.

Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-11-17

Evidence over time

2026An Adipose Mast-Cell Activation and Type-2 Orchestration Endotype of Lipedema: A Testable Neuroimmune Framework — Amato ACM. (2026) · contextual

Evidence (1)

Context (PECO)

Populationwomen with lipedema (conceptual framework)
Conditionlipedema
ExposureADHD-related neuroimmune concepts (exploratory hypothesis)
Outcomeproposed lipedema endotype / comorbidity associations
Scopeauto-ingested from Layer 1 surveillance

Answers these questions

Gaps & caveats

Auto-ingested single source; not yet human-reviewed.

Change log